Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease

Journal of Investigative Dermatology

Volumn 108, Issue 1, 1997, Pages 103-107

  Chren, Mary Margaret ^a,b,c   Lasek, Rebecca J ^a,b   Quinn, Linda M ^b   Covinsky, Kenneth E ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Health status measure; Psychometric testing

Indexed keywords

ADULT; ARTICLE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SKIN DISEASE;

EID: 0031016418     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12285650     Document Type: Article

References (26)

1. American College of Physicians: Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 117:1038-1041, 1992
2. Bombardier C, Melfi CA, Paul J, Green K, Hawker G, Wright J, Coyte P: Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery. Med Care 33:AS131-AS144, 1995
3. Charlson ME, Pompei PP, Ales KL, Mackenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383, 1987
4. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ: Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest dermatol 107:707-713, 1996
5. Cox J, Naylor CD: The Canadian Cardiovascular Society grading scale for angina pectoris: is it time for refinements? Ann Intern Med 117:677-683, 1992
6. Eddy HM: Connecting value and costs. Whom do we ask, and what do we ask them? JAMA 264:1737-1739, 1990
7. Finlay AY, Kelly SE: Psoriasis - an index of disability. Clin Exp Dermatol 12:8-11, 1987
8. Finlay AY, Khan GK, Luscomhe DK, Salek MS: Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Br J Dermatol 123:751-756, 1990
9. Guyatt GH, Eagle DJ, Sackett B, Willan A, Griffith L, McIlroy W, Patterson CJ, Turpie I: Measuring quality of life in the frail elderly. J Clin Epidemiol 46:1433-1444, 1993
10. Hlatky MA: Patient preferences and clinical guidelines. JAMA 273:1219-1220, 1995
11. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH: Comparative measurement sensitivity of short and longer health status instruments. Med Care 30:917-925, 1992
12. Lindholm C, Bjellerup M, Christensen OB, Zederfeldt B: Quality of life in chronic leg ulcer patients. An assessment according to the Nottingham Health Profile. Acta Dermatol Venerol (Stockh) 73:440-443, 1993
13. McDowell I, Newell C: Measuring Health. A Guide to Rating Scales and Questionnaires. 2nd ed. Oxford University Press, New York, 1996
14. McHorney CA, Ware JE, Lu JFR, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40-66, 1994
15. McHorney CA, Ware JE, Kaczek AE: The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247-263, 1993
16. McNeil BJ, Weichselbaum R, Pauker SG: Fallacy of the five-year survival in lung cancer. N Engl J Med 299:1397-1401, 1978
17. Nease Jr RF, Kneeland T, O'Connor GT, Sumner W, Lumpkins C, Shaw L, Pryor D, Sox HC: Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. JAMA 273:1185-1190, 1995
18. O'Connor AMC, Boyd NF, Warde P, Stolbach L, Till JE: Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis 40:811-818, 1987
19. Patrick DL, Deyo KA: Generic and disease-specific measures in assessing health status and quality of life. Med Care 27:S217-S232, 1989
20. Patrick DL, Deyo RA, Atlas SJ, Singer DE, Chapin A, Keller RB: Assessing health-related quality of life in patients with sciatica. Spine 20:1899-1909, 1995
21. Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RDR, Graham-Brown RAC, Khan GK, Marks R, Motley RJ, Ross JS, Sowden JM: Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 129:422-430, 1993
22. Salek MS, Kahn GK, Finlay AY: Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual Life Res 5:131-138, 1996
23. Ware J: SF-36 Health Surrey Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, 1993
24. Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483, 1992
25. Wilson IB, Cleary PD: Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273:59-65, 1995
26. Ziebland S, Fitzpatrick R, Jenkinson C: Tacit models of disability underlying health status instruments. Soc Sci Med 37:69-75, 1993